Scientists discover new way to tackle inflammatory diseases

February 27, 2014 by Shemina Davis
Scientists discover new way to tackle inflammatory diseases
Zebrafish inflammatory neutrophils (in red) leave sites of inflammation when treated with Tanshinone

Researchers at the University of Sheffield have found a potential new way to treat common and largely incurable inflammatory conditions like chronic obstructive pulmonary disease (COPD).

Normally when a person is injured or gets an infection, the body sends specialist white blood cells (neutrophils) to clean up the area, resulting in it becoming red and inflamed. The inflammation usually ebbs away over time but in certain diseases the inflammation remains, doing more damage to surrounding tissue.

Now scientists from the University of Sheffield may have found a solution using an ingredient found in traditional Chinese medicine which has inflammation reducing capabilities, giving it the potential to treat a range of diseases.

By screening drugs in zebrafish, researchers found a compound, Tanshinone IIA, which reduced inflammation, removing neutrophils by causing them to die at the wound and by moving them away from the wound - a completely new way to treat . The discovery has, for the first time, given scientists the opportunity to develop anti-inflammatory drugs which would not increase the risk of infection like current treatments.

Professor Stephen Renshaw, from the University's Department of Infection and Immunity, said: "Chronic inflammatory diseases are a major cause of illness and death worldwide and many of these, such as chronic (COPD) are characterised by the persistence of inflammatory neutrophils. We believe targeting the neutrophil would be a new way to bring about healing in these conditions.

"Sending immune cells away from damaged tissue might be a good way to allow the damage to heal while still allowing those to protect us against infection."

Professor Renshaw said it was not known at the moment precisely how Tanshinone IIA helps to migrate away from the wound but said research would continue.

He added: "Tanshinone IIA might be the first in a new class of drugs that allows us to tackle some devastating conditions, benefiting thousands of sufferers."

The research work was funded by the Medical Research Council (MRC) and the full paper will be published in the Science Translational Medicine journal.

Related Stories

Blocking inflammation could lead to tailored medical treatments

September 19, 2011

By using a mouse model of inflammation researchers at the University of Calgary have discovered a new class of molecules that can inhibit the recruitment of some white blood cells to sites of inflammation in the body. A provisional ...

New blood cells fight brain inflammation

February 16, 2014

Hyperactivity of our immune system can cause a state of chronic inflammation. If chronic, the inflammation will affect our body and result in disease. In the devastating disease multiple sclerosis, hyperactivity of immune ...

Recommended for you

Crystal clear images uncover secrets of hormone receptors

July 31, 2015

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells. NIH scientists used atomic level ...

A cheaper, high-performance prosthetic knee

July 30, 2015

In the last two decades, prosthetic limb technology has grown by leaps and bounds. Today, the most advanced prostheses incorporate microprocessors that work with onboard gyroscopes, accelerometers, and hydraulics to enable ...

Flow means 'go' for proper lymph system development

July 27, 2015

The lymphatic system provides a slow flow of fluid from our organs and tissues into the bloodstream. It returns fluid and proteins that leak from blood vessels, provides passage for immune and inflammatory cells from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.